| Feature | Detail |
|---|---|
| Issuer | HSBC Holdings plc |
| Amount | US$1,500,000,000 |
| Coupon | 6.750% |
| Instrument | Perpetual Subordinated Contingent Convertible Securities |
| Intended issue date | May 18, 2026 |
| ISIN | US404280FR58 |
| Call wording | Callable during any optional redemption period, as defined in the securities documentation |
| Expected listing | Admission to the Official List and trading on Euronext Dublin’s Global Exchange Market within 30 days of the issue date |
The May filing identifies one US$1.5 billion series, making it a cleaner structure than HSBC’s March transaction, which was split into two separate AT1 tranches.
The official May announcement says the securities are Callable During Any Optional Redemption Period, as defined in the relevant documentation. It also labels the securities as perpetual, meaning the instrument is not presented as a conventional dated bond with a fixed final maturity.
The important limitation is that the supplied filing excerpt does not show the first optional redemption date, reset terms, or the full mechanics of the optional redemption period for the May 2026 securities. That makes the May deal harder to compare precisely with HSBC’s March AT1, where the two tranches were explicitly described as callable during the 2031 and 2036 securities optional redemption periods.
HSBC’s March 2026 AT1 transaction raised US$2.5 billion across two US$1.25 billion tranches: a 6.750% perpetual subordinated contingent convertible security tied to a 2031 optional redemption period, and a 7.000% security tied to a 2036 optional redemption period.
| Comparison point | May 2026 planned AT1 | March 2026 AT1 |
|---|---|---|
| Total size | US$1.5 billion | US$2.5 billion |
| Structure | One identified US$1.5 billion series | Two US$1.25 billion tranches |
| Coupon | 6.750% | 6.750% on the 2031 securities and 7.000% on the 2036 securities |
| Call description | Callable during any optional redemption period | Callable during any 2031 or 2036 securities optional redemption period, depending on tranche |
| Market context | HSBC’s second dollar AT1 sale since March, according to market coverage | Reported as reopening the major-currency AT1 market after Iran-related market disruption |
The simplest read is that HSBC is adding another AT1 instrument at the same 6.750% coupon as the lower-coupon March tranche, but in a smaller single-series format.
AT1 issuance is highly sensitive to funding cost. When investor demand improves and spreads tighten, banks can issue loss-absorbing capital at a lower yield premium, making new deals or refinancing more attractive. Market coverage of HSBC’s May return described the cost of capital as attractive enough to lure bank issuers back, while noting that HSBC was marketing a new dollar AT1 less than two months after raising US$2.5 billion in March.
The March deal also showed the depth of investor demand. GlobalCapital reported that HSBC’s US$2.5 billion AT1 sale was supported by a US$17 billion order book. Another market report said pricing tightened by about half a percentage point from initial guidance after solid demand, with the securities ultimately priced to yield 6.75% and 7.00%.
That said, the supplied sources do not provide a full current spread series or a market-wide issuance calendar. The evidence supports a more cautious conclusion: conditions have improved enough for HSBC to return quickly, but it does not prove that every bank issuer can access the AT1 market on similarly attractive terms.
The May securities are officially described as perpetual subordinated contingent convertible securities, the form used for AT1-style bank capital instruments. The provided May source does not include a detailed operating use-of-proceeds paragraph, so it would be unsupported to claim the money is earmarked for a specific loan book, acquisition, dividend, or business line.
The capital-base logic is instead structural. AT1 instruments are designed as loss-absorbing bank capital; the supplied market summary notes that European and UK regulators continue to support AT1s as loss-absorbing tools. HSBC’s March AT1 coverage also described that issuance as intended to strengthen the bank’s capital base. On that basis, the May issue should be read primarily as a regulatory-capital transaction, subject to the securities meeting the relevant recognition criteria and final terms.
HSBC’s repeat issuance is a positive signal for the AT1 pipeline, but not a blanket reopening guarantee. On the positive side, HSBC is returning with another dollar AT1 after a March transaction that market reports said drew a US$17 billion book. GlobalCapital’s market page also described attractive capital costs as a lure for bank issuers and pointed to Belfius Bank as a possible candidate for further AT1 issuance.
The caveat is that the sources provided here are strongest on HSBC’s own transactions, not on the entire global AT1 calendar. The prudent conclusion is that investor appetite and pricing have improved enough for a major issuer such as HSBC to come back to market quickly, while future issuance will still depend on volatility, secondary-market spreads, order-book depth, and the exact call and reset terms investors are offered.
HSBC’s planned May 18, 2026 AT1 is a US$1.5 billion, 6.750% perpetual subordinated contingent convertible issue with callability during an optional redemption period. It is smaller than the bank’s US$2.5 billion March AT1 sale, but its timing reinforces the message that the AT1 market is open for at least some large bank issuers when demand is strong and funding costs are acceptable.